| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
9,867 |
5,451 |
$310K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,731 |
2,308 |
$242K |
| J3490 |
Unclassified drugs |
7,834 |
2,721 |
$125K |
| A9270 |
Non-covered item or service |
8,174 |
1,127 |
$64K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,422 |
326 |
$55K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
302 |
278 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
1,152 |
925 |
$21K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
160 |
134 |
$16K |
| 80053 |
Comprehensive metabolic panel |
1,087 |
892 |
$16K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
222 |
200 |
$14K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
202 |
171 |
$10K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
682 |
407 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
340 |
251 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
318 |
272 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
410 |
264 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
229 |
37 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
141 |
105 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
88 |
72 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,915 |
1,521 |
$3K |
| 11720 |
|
240 |
103 |
$3K |
| 11721 |
|
100 |
68 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
209 |
88 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
35 |
35 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
86 |
82 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
34 |
30 |
$817.29 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16 |
13 |
$471.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
13 |
$358.97 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
59 |
39 |
$93.05 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
96 |
44 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
136 |
130 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
366 |
345 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
14 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
12 |
$0.00 |
| 81001 |
|
17 |
16 |
$0.00 |